The Prince Charles Hospital
🇦🇺Australia
Clinical Trials
30
Active:0
Completed:12
Trial Phases
4 Phases
Phase 1:4
Phase 2:1
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (29 trials with phase data)• Click on a phase to view related trials
Not Applicable
22 (75.9%)Phase 1
4 (13.8%)Phase 4
2 (6.9%)Phase 2
1 (3.4%)Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3
Not Applicable
Withdrawn
- Conditions
- Sleep Disordered Breathing CentralBronchiolitis Obliterans
- First Posted Date
- 2014-04-09
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- The Prince Charles Hospital
- Registration Number
- NCT02109237
- Locations
- 🇦🇺
The Prince Charles Hospital, Brisbane, Queensland, Australia
Desensitising Celiac Disease Patients With the Human Hookworm
Phase 1
Completed
- Conditions
- Celiac Disease
- First Posted Date
- 2012-08-10
- Last Posted Date
- 2014-10-20
- Lead Sponsor
- The Prince Charles Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT01661933
- Locations
- 🇦🇺
Prince Charles Hospital, Chermside, Queensland, Australia
A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- The Prince Charles Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT01385644
- Locations
- 🇦🇺
The Prince Charles Hospital, Brisbane, Queensland, Australia
A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation
Phase 1
Completed
- Conditions
- Lung TransplantationBronchiolitis Obliterans
- First Posted Date
- 2010-08-05
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- The Prince Charles Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01175655
- Locations
- 🇦🇺
TPCH, Brisbane, Queensland, Australia
🇦🇺RPH, Perth, Western Australia, Australia
Tirofiban and Enoxaparin in High Risk Coronary Intervention
Phase 4
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2010-03-24
- Lead Sponsor
- The Prince Charles Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT00790387
- Locations
- 🇦🇺
The Prince Charles Hospital, Brisbane, Queensland, Australia
News
No news found